The effect of isoflavones in endometriotic pai
- Conditions
- endometriosis
- Registration Number
- JPRN-jRCTs051200074
- Lead Sponsor
- Taisuke Mori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 110
In patients diagnosed with endometriosis,
(1) Patients younger than 45 years of age who are 20 years old or older
(2) Patients with chronic pelvic pain with a menstrual cycle period of 25 to 38 days and VAS 2.0 or higher
(1) Patients who used dietary supplements containing soy isoflavones within 3 months of their visit
(2) Within 3 months from the visit, GnRH analog preparation, endocrine preparation mainly composed of luteinizing hormone or follicular hormone, low-dose pill, medium-dose pill, testosterone derivative and Chinese medicine with indication for endometriosis were used patient
(3) Patients who have undergone surgical treatment for endometriosis with transvaginal alcohol fixation, laparotomy, and laparoscope within 3 months after consultation
(4) Patients who are pregnant or suspected of being pregnant at the time of consultation
(5) Patients who are lactating women at the time of consultation
(6) Patients judged by the attending physician as inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method